Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Samarth Kulkarni currently holds 311,899 shares of CRISPR Therapeutics AG (CRSP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Samarth Kulkarni has been a net seller of CRSP stock. They have purchased $0 and sold $55.7M worth of shares.
Samarth Kulkarni's most recent insider trade was on Oct 19, 2026, when they sold 47,837 shares at $49.78 per share.
Samarth Kulkarni serves as Executive at CRISPR Therapeutics AG (CRSP). They have executed 204 insider transactions totaling $55.7M over their tenure at the company.
Samarth Kulkarni holds the position of Executive at CRISPR Therapeutics AG, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Samarth Kulkarni has shown a selling trading pattern, with $0 in total purchases and $55.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Samarth Kulkarni was on Oct 17, 2025, when they sold $3.5M worth of CRSP shares. This transaction involved 50,895 shares at $67.91 per share.
Samarth Kulkarni currently owns 311,899 shares of CRISPR Therapeutics AG (CRSP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Samarth Kulkarni's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Samarth Kulkarni has 204 Form 4 filings on record as an insider at CRISPR Therapeutics AG.
Set alerts for Samarth Kulkarni and 40,000+ other insiders.